Library Subscription: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Published 6 issues per year

ISSN Print: 0743-4863

ISSN Online: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Caveolae—An Alternative Endocytotic Pathway for Targeted Drug Delivery

Volume 21, Issue 2, 2004, 30 pages
DOI: 10.1615/CritRevTherDrugCarrierSyst.v21.i2.10
Get accessGet access

ABSTRACT

Caveolae are bottleshape-like invaginations of the plasma membrane. After internalization they are involved in endocytosis, transcytosis, potocytosis, and pinocytosis. Our recently expanded knowledge has made clear that various molecules and macromolecular complexes enter the cells after docking on caveolar receptors, before subsequent internalization of the caveolae. The internalization is initiated by the ligand receptor interaction. Folate, cholesterol, serum lipoproteins, and liposomes are among the most common examples. It is important to point out that, in contrast to the classic clathrin-dependent endocytosis, the caveolar internalization pathway seems to avoid the lysosomes. Internalized caveolae fuse with caveosomes, and the caveosomes deliver their contents into other subcellular (non-lysosomal) compartments. The bypass of the acidic and harmful milieu might be a major advantage for drug delivery via the caveolar pathway. Not all cell types have caveolae. Cells, where the Caveolin I protein is not expressed, do not develop caveolar invaginations. However, these cells have caveolar-equivalent plasma membrane domains, so-called "lipid rafts." Lipid rafts are assembled from the same lipid constituents and proteins as caveolae, but they are flat. Specific ligands may also dock on appropriate receptors of the raft domain. As a complication, certain types of ligand-covered raft receptors can migrate to clathrin-coated pits and get internalized via clathrin-coated vesicles. Nevertheless, suitable ligands or antibodies developed against proteins of the caveolar/raft domains may selectively direct the attached drug carrier to the less harmful caveolar/raft pathway. Thus, understanding of caveolar transport may help in the rational design of more effective drug carriers.

CITED BY
  1. Letoha Tamás, Gaál Szilvia, Somlai Csaba, Venkei Zsolt, Glavinas Hristos, Kusz Erzsébet, Duda Ernö, Czajlik András, Peták Ferenc, Penke Botond, Investigation of penetratin peptides. Part 2.In vitro uptake of penetratin and two of its derivatives, Journal of Peptide Science, 11, 12, 2005. Crossref

  2. Villeneuve David J., Hembruff Stacey L., Veitch Zachary, Cecchetto Melanie, Dew William A., Parissenti Amadeo M., cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance, Breast Cancer Research and Treatment, 96, 1, 2006. Crossref

  3. Bengali Zain, C.Rea Jennifer, Shea Lonnie D., Gene expression and internalization following vector adsorption to immobilized proteins: dependence on protein identity and density, The Journal of Gene Medicine, 9, 8, 2007. Crossref

  4. Kreyling Wolfgang G., Semmler-Behnke Manuela, Möller Winfried, Dosimetry, Epidemiology and Toxicology of Nanoparticles, in Nanotechnologies for the Life Sciences, 2007. Crossref

  5. Kreyling Wolfgang G., Semmler-Behnke Manuela, Möller Winfried, Health implications of nanoparticles, Journal of Nanoparticle Research, 8, 5, 2006. Crossref

  6. Ge Shujun, Song Li, Serwanski David R., Kuziel William A., Pachter Joel S., Transcellular transport of CCL2 across brain microvascular endothelial cells, Journal of Neurochemistry, 104, 5, 2008. Crossref

  7. Pelletier R.-Marc, The blood-testis barrier: the junctional permeability, the proteins and the lipids, Progress in Histochemistry and Cytochemistry, 46, 2, 2011. Crossref

  8. Wang Ping, Liu Yunhui, Shang Xiuli, Xue Yixue, CRM197-Induced Blood–Brain Barrier Permeability Increase is Mediated by Upregulation of Caveolin-1 Protein, Journal of Molecular Neuroscience, 43, 3, 2011. Crossref

  9. Parmentier Johannes, Hartmann Felix J., Fricker Gert, In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules, European Journal of Pharmaceutics and Biopharmaceutics, 76, 3, 2010. Crossref

  10. Johnson Paul H., Frank Diane, Cui Kunyuan, Adami Roger, Wang Harry, Houston Michael, Quay Steven C., Discovery of New SiRNA Delivery Agents, in RNA Interference, 2010. Crossref

  11. Raemdonck Koen, Martens Thomas F., Braeckmans Kevin, Demeester Jo, De Smedt Stefaan C., Polysaccharide-based nucleic acid nanoformulations, Advanced Drug Delivery Reviews, 65, 9, 2013. Crossref

  12. Cohen-Sela Einat, Elazar Victoria, Epstein-Barash Hila, Golomb Gershon, Nano-Carriers of Drugs and Genes for the Treatment of Restenosis, in Nanoparticulate Drug Delivery Systems, 20075578, 2007. Crossref

  13. Biswas Swati, Torchilin Vladimir P., Nanopreparations for organelle-specific delivery in cancer, Advanced Drug Delivery Reviews, 66, 2014. Crossref

  14. Zidan Ahmed S., Spinks Crystal B., Habib Muhammad J., Khan Mansoor A., Formulation and transport properties of tenofovir loaded liposomes through Caco-2 cell model, Journal of Liposome Research, 23, 4, 2013. Crossref

  15. Liang Wanling, Kwok Philip C.L., Chow Michael Y.T., Tang Patricia, Mason A. James, Chan Hak-Kim, Lam Jenny K.W., Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids, European Journal of Pharmaceutics and Biopharmaceutics, 86, 1, 2014. Crossref

  16. Lam Jenny K W, Armes Steve P, Stolnik Snjezana, The involvement of microtubules and actin filaments in the intracellular transport of non-viral gene delivery system, Journal of Drug Targeting, 19, 1, 2011. Crossref

  17. Deady Lauren, Cox James L., Uptake of Cystatin by Melanoma Cells in Culture, CellBio, 02, 02, 2013. Crossref

  18. Hosseini A., Soleimani Sh., Pezeshgi Modarres H., Hojjati Emami Sh., Tondar M., Bahlakeh G., Hasani-Sadrabadi M. M., Exosome-inspired targeting of cancer cells with enhanced affinity, Journal of Materials Chemistry B, 4, 4, 2016. Crossref

  19. Perez Ruiz de Garibay Aritz, Endocytosis in gene therapy with non-viral vectors, Wiener Medizinische Wochenschrift, 166, 7-8, 2016. Crossref

  20. Fang Bing, Zhang Ming, Wu Hongyan, Fan Xing, Ren Fazheng, Internalization properties of the anti-tumor α-lactalbumin-oleic acid complex, International Journal of Biological Macromolecules, 96, 2017. Crossref

  21. Peñaloza Juan P., Márquez-Miranda Valeria, Cabaña-Brunod Mauricio, Reyes-Ramírez Rodrigo, Llancalahuen Felipe M., Vilos Cristian, Maldonado-Biermann Fernanda, Velásquez Luis A., Fuentes Juan A., González-Nilo Fernando D., Rodríguez-Díaz Maité, Otero Carolina, Intracellular trafficking and cellular uptake mechanism of PHBV nanoparticles for targeted delivery in epithelial cell lines, Journal of Nanobiotechnology, 15, 1, 2017. Crossref

  22. Serda Rita E., Adolphi Natalie L., Bisoffi Marco, Sillerud Laurel O., Targeting and Cellular Trafficking of Magnetic Nanoparticles for Prostate Cancer Imaging, Molecular Imaging, 6, 4, 2007. Crossref

  23. Xiang Shengnan, Sarem Melika, Shah Samveg, Shastri V. Prasad, Liposomal Treatment of Cancer Cells Modulates Uptake Pathway of Polymeric Nanoparticles by Altering Membrane Stiffness, Small, 14, 14, 2018. Crossref

  24. Kiani Maria Hassan, Yasinzai Masoom, Shahnaz Gul, Multifunctional Polymeric Enveloped Nanocarriers: Targeting Extracellular and Intracellular Barriers, in Molecular Insight of Drug Design, 2018. Crossref

  25. Liu Yan, Xu Yawen, Geng Xiangshuai, Huo Yingying, Chen Dexin, Sun Kang, Zhou Guangdong, Chen Biqiong, Tao Ke, Synergistic Targeting and Efficient Photodynamic Therapy Based on Graphene Oxide Quantum Dot-Upconversion Nanocrystal Hybrid Nanoparticles, Small, 14, 19, 2018. Crossref

  26. Dopico Alex M., Tigyi Gabor J., A Glance at the Structural and Functional Diversity of Membrane Lipids, in Methods in Membrane Lipids, 400, 2007. Crossref

  27. Torchilin Vladimir P., Nanotechnology for Intracellular Delivery and Targeting, in Nanotechnology in Drug Delivery, 2009. Crossref

  28. Arima Hidetoshi, Dendrimers as DNA Carriers, in Non-viral Gene Therapy, 2005. Crossref

  29. Kovvasu Surya Prakasarao, Kunamaneni Priyanka, Yeung Steven, Rueda Javier, Betageri Guru V., Formulation of Dronedarone Hydrochloride-Loaded Proliposomes: In Vitro and In Vivo Evaluation Using Caco-2 and Rat Model, AAPS PharmSciTech, 20, 6, 2019. Crossref

  30. Bonor Jeremy, Nohe Anja, Image Correlation Spectroscopy to Define Membrane Dynamics, in Live Cell Imaging, 591, 2010. Crossref

  31. Moura Rui Pedro, Martins Cláudia, Pinto Soraia, Sousa Flávia, Sarmento Bruno, Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology, Expert Opinion on Drug Delivery, 16, 3, 2019. Crossref

  32. Yasuoka Hidekata, Garrett Sara M., Nguyen Xinh-Xinh, Artlett Carol M., Feghali-Bostwick Carol A., NADPH oxidase-mediated induction of reactive oxygen species and extracellular matrix deposition by insulin-like growth factor binding protein-5, American Journal of Physiology-Lung Cellular and Molecular Physiology, 316, 4, 2019. Crossref

  33. Chiu Chang-Ta, Lin Che-Yi, Yen Ching-Yu, Tsai Meng-Ting, Chang Huei-Cih, Liu Young-Chau, Lin Mei-Huei, Mechanistic and compositional studies of the autophagy-inducing areca nut ingredient, Journal of Dental Sciences, 15, 4, 2020. Crossref

  34. Kimura Seigo, Harashima Hideyoshi, Current Status and Challenges Associated with CNS-Targeted Gene Delivery across the BBB, Pharmaceutics, 12, 12, 2020. Crossref

  35. Wimalachandra Dulani Chandima, Li Yong, Liu Jinliang, Shikha Swati, Zhang Jing, Lim Yaw-Chyn, Zhang Yong, Microfluidic-Based Immunomodulation of Immune Cells Using Upconversion Nanoparticles in Simulated Blood Vessel–Tumor System, ACS Applied Materials & Interfaces, 11, 41, 2019. Crossref

  36. Torchilin Vladimir P., RECENT APPROACHES TO INTRACELLULAR DELIVERY OF DRUGS AND DNA AND ORGANELLE TARGETING, Annual Review of Biomedical Engineering, 8, 1, 2006. Crossref

  37. Franzen Stefan, Lommel Steven A, Targeting cancer with ‘smart bombs’: equipping plant virus nanoparticles for a ‘seek and destroy’ mission, Nanomedicine, 4, 5, 2009. Crossref

  38. Barth Brian M., I. Altinoğlu Erhan, Shanmugavelandy Sriram S., Kaiser James M., Crespo-Gonzalez Daniza, DiVittore Nicole A., McGovern Christopher, Goff Trevor M., Keasey Nicole R., Adair James H., Loughran Thomas P., Claxton David F., Kester Mark, Targeted Indocyanine-Green-Loaded Calcium Phosphosilicate Nanoparticles for In Vivo Photodynamic Therapy of Leukemia, ACS Nano, 5, 7, 2011. Crossref

  39. Locke Darren, Liu Jade, Harris Andrew L., Lipid Rafts Prepared by Different Methods Contain Different Connexin Channels, but Gap Junctions Are Not Lipid Rafts, Biochemistry, 44, 39, 2005. Crossref

  40. Graceffa Valeria, Physical and mechanical cues affecting biomaterial-mediated plasmid DNA delivery: insights into non-viral delivery systems, Journal of Genetic Engineering and Biotechnology, 19, 1, 2021. Crossref

  41. Mazumdar Samrat, Chitkara Deepak, Mittal Anupama, Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers, Acta Pharmaceutica Sinica B, 11, 4, 2021. Crossref

  42. Du Hongliang, Yang Xiaoye, Zhai Guangxi, Design of chitosan-based nanoformulations for efficient intracellular release of active compounds, Nanomedicine, 9, 5, 2014. Crossref

  43. Linnane Emily, Fairen-Jimenez David, Metal-Organic Frameworks as Delivery Systems of Small Drugs and Biological Gases, in Metal-Organic Frameworks in Biomedical and Environmental Field, 2021. Crossref

  44. Meng Jianing, Zhang Tao, Agrahari Vivek, Ezoulin Miezan J, Youan Bi-Botti C, Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention, Nanomedicine, 9, 11, 2014. Crossref

  45. Rea Jennifer C., Gibly Romie F., Davis Nicolynn E., Barron Annelise E., Shea Lonnie D., Engineering Surfaces for Substrate-Mediated Gene Delivery Using Recombinant Proteins, Biomacromolecules, 10, 10, 2009. Crossref

  46. LoRusso Patricia M., Edelman Martin J., Bever Susan L., Forman Karen M., Pilat MaryJo, Quinn Mary F., Li Jing, Heath Elisabeth I., Malburg Lisa M., Klein Patrick J., Leamon Christopher P., Messmann Richard A., Sausville Edward A., Phase I Study of Folate Conjugate EC145 (Vintafolide) in Patients With Refractory Solid Tumors, Journal of Clinical Oncology, 30, 32, 2012. Crossref

  47. Shmeeda Hilary, Mak Lidia, Tzemach Dina, Astrahan Peleg, Tarshish Mark, Gabizon Alberto, Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors, Molecular Cancer Therapeutics, 5, 4, 2006. Crossref

  48. Giordano Nicole P., Cian Melina B., Dalebroux Zachary D., Richardson Anthony R., Outer Membrane Lipid Secretion and the Innate Immune Response to Gram-Negative Bacteria, Infection and Immunity, 88, 7, 2020. Crossref

  49. Cui Jiwei, Xu Yuanxin, Tu Haiyan, Zhao Huacong, Wang Honglan, Di Liuqing, Wang Ruoning, Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas, Acta Pharmaceutica Sinica B, 12, 3, 2022. Crossref

  50. Kovács Dávid, Igaz Nóra, Gopisetty Mohana K., Kiricsi Mónika, Cancer Therapy by Silver Nanoparticles: Fiction or Reality?, International Journal of Molecular Sciences, 23, 2, 2022. Crossref

  51. Sheikh Afsana, Md Shadab, Alhakamy Nabil A., Kesharwani Prashant, Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics, International Journal of Pharmaceutics, 620, 2022. Crossref

  52. Meter Diana, Racetin Anita, Vukojević Katarina, Balog Marta, Ivić Vedrana, Zjalić Milorad, Heffer Marija, Filipović Natalija, A Lack of GD3 Synthase Leads to Impaired Renal Expression of Connexins and Pannexin1 in St8sia1 Knockout Mice, International Journal of Molecular Sciences, 23, 11, 2022. Crossref

  53. Liu Hui, Zhao Xiaoyun, Bai Yu, Xie Huichao, Yang Zhen, Wang Yichen, Chen Yongfeng, Luo Yucen, Ma Mengrui, Lu Wenwen, Ma Jizhuang, Yang Tianzhi, Jin Bo, Ding Pingtian, Amphiphilic cationic triblock polymers for p53-mediated triple-negative breast cancer gene therapy, Materials & Design, 219, 2022. Crossref

  54. Sastri K. Trideva, Gupta N. Vishal, M Sharadha, Chakraborty Souvik, Kumar Hitesh, Chand Pallavi, Balamuralidhara V., Gowda D.V., Nanocarrier facilitated drug delivery to the brain through intranasal route: A promising approach to transcend bio-obstacles and alleviate neurodegenerative conditions, Journal of Drug Delivery Science and Technology, 75, 2022. Crossref

  55. Mlakar Logan, Garrett Sara M., Watanabe Tomoya, Sanderson Matthew, Nishimoto Tetsuya, Heywood Jonathan, Helke Kristi L., Pilewski Joseph M., Herzog Erica L., Feghali-Bostwick Carol, Ameliorating Fibrosis in Murine and Human Tissues with END55, an Endostatin-Derived Fusion Protein Made in Plants, Biomedicines, 10, 11, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain